Smith Group Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,360	Closed	-$41K	–	407
2019 Q1	$41K	Sell	1,360 -80	-6%	-$2.74K	﹤0.01%	311
2018 Q4	$48K	Hold	1,440	–	–	﹤0.01%	302
2018 Q3	$61K	Hold	1,440	–	–	﹤0.01%	292
2018 Q2	$46K	Hold	1,440	–	–	﹤0.01%	337
2018 Q1	$72K	Sell	1,440 -50	-3%	-$2.83K	﹤0.01%	316
2017 Q4	$80K	Hold	1,490	–	–	﹤0.01%	296
2017 Q3	$86K	Sell	1,490 -1,410	-49%	-$73.7K	﹤0.01%	295
2017 Q2	$143K	Sell	2,900 -1,330	-31%	-$61.2K	﹤0.01%	281
2017 Q1	$184K	Sell	4,230 -2,030	-32%	-$96.9K	0.01%	278
2016 Q4	$306K	Sell	6,260 -200	-3%	-$9.25K	0.01%	220
2016 Q3	$309K	Buy	6,460 +130	+2%	+$6.42K	0.01%	216
2016 Q2	$340K	Sell	6,330 -65,070	-91%	-$3.07M	0.01%	210
2016 Q1	$3.19M	Buy	71,400 +250	+0.4%	+$10.1K	0.1%	105
2015 Q4	$2.71M	Buy	71,150 +69,440	+4,061%	+$2.66M	0.08%	118
2015 Q3	$54K	Sell	1,710 -113	-6%	-$3.94K	﹤0.01%	283
2015 Q2	$59K	Sell	1,823 -91,184	-98%	-$3.25M	﹤0.01%	276
2015 Q1	$3.83M	Sell	93,007 -5,120	-5%	-$207K	0.13%	113
2014 Q4	$4M	Sell	98,127 -2,840	-3%	-$111K	0.14%	118
2014 Q3	$3.7M	Buy	100,967 +653	+0.7%	+$28.2K	0.14%	122
2014 Q2	$4.65M	Sell	100,314 -15,909	-14%	-$708K	0.17%	104
2014 Q1	$4.78M	Sell	116,223 -16,169	-12%	-$601K	0.18%	100
2013 Q4	$5.05M	Sell	132,392 -18,499	-12%	-$571K	0.19%	96
2013 Q3	$3.6M	Sell	150,891 -15,582	-9%	-$350K	0.15%	116
2013 Q2	$2.83M	Buy	+166,473	New	+$2.4M	0.12%	142